Cardiac troponins in renal insufficiency: review and clinical implications.
about
Troponin elevation in conditions other than acute coronary syndromesCardiac Troponins in Dogs and CatsChief Complaint at Admission Relates to Troponin Level and Mortality in Patients With Non-ACS Troponin Elevation.Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional studyDiagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trialEndotoxemia is associated with acute coronary syndrome in patients with end stage kidney diseaseTroponin: the biomarker of choice for the detection of cardiac injuryThe association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study.The utility of troponin measurement to detect myocardial infarction: review of the current findings.Association of glomerular filtration rate with high-sensitivity cardiac troponin T in a community-based population study in BeijingSensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.Role of biomarkers in risk stratification of acute coronary syndromeSubclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?A more appropriate cardiac troponin T level that can predict outcomes in end-stage renal disease patients with acute coronary syndrome.Troponin elevation in acute ischemic stroke (TRELAS)--protocol of a prospective observational trialHigh-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarctionElevated troponin T after acute ischemic stroke: Association with severity and location of infarction.Troponin I, laboratory issues, and clinical outcomes in a district general hospital: crossover study with "traditional" markers of myocardial infarction in a total of 1990 patients.Tegaserod-induced myocardial infarction: case report and hypothesis.Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease.MicroRNAs in patients on chronic hemodialysis (MINOS study).High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well?Avoiding false discovery in biomarker research.Cardiovascular risk in chronic renal disease and transplantation prevention and management.Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).Cardiac enzymes, renal failure and renal transplantation.Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.Troponin elevation predicts critical care needs and in-hospital mortality after thrombolysis in white but not black stroke patients.Neutrophil to lymphocyte ratio might help prediction of acute myocardial infarction in patients with elevated serum creatinineDetectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.Elevation of troponin I in acute ischemic stroke.Serum cardiac troponin I concentrations in dogs with systemic inflammatory response syndrome.Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.Increased troponin levels in nonischemic cardiac conditions and noncardiac diseases.Biomarkers in Acute Coronary Syndrome.Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future.Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.
P2860
Q24630238-6614190F-A796-47C3-8AAE-CDB011500951Q26774969-B99E907F-F087-47DF-88AB-BFB5B191CB9EQ33165629-C0ED1995-6D19-429D-BB37-9F81FC995BA5Q33483732-8695E346-F41D-4276-AB66-7C560A172267Q33854806-BBAF9DBD-DDED-4ED0-912E-B874F8F619DEQ33901115-F45A29C1-B145-4D98-A8C6-037274A0B507Q34117708-E5B271A1-4D9A-4B71-B46D-0F7447B87FE2Q34128699-24296907-B992-4D55-BE9C-365F783FF8B0Q34139055-27709DE8-C1B7-4289-99AC-CD42C06C39A1Q34295470-9FECB476-22C3-4BC7-AA74-BE2C213A2204Q34451008-09416774-E514-45A4-ABD2-5E73D1ADAA87Q34453236-A62A7674-965C-4F02-B1AC-BB5028F5E110Q34530136-18D2AB5D-542D-4A06-BB7C-82D05B62F2A5Q34610511-81E8310D-393D-4C90-9C0D-B5FBA6AA6D3CQ34980234-34CA2A80-076E-4A1C-8957-7A8569B90300Q35014777-280E1C38-F4F4-41F8-94C9-8846CCFC5591Q35196125-6CCEE950-E3B2-497F-9AE0-802F0D5C1426Q35228547-21C0F2D5-9C64-4C38-A5B6-55E6B30B9829Q35326877-98B9E9C1-1EEE-417E-93B0-EDDA3DDE2133Q35399464-C33A38E6-6245-4BB2-BB30-A883FE61E638Q35588038-00DDBA20-4FC5-45B5-99F7-2501CBA02142Q35751537-E0AA08C6-6D75-46A4-9AB8-661D55869DBEQ35791735-F28567D6-01C9-43C5-A836-4664A063AA25Q35860686-767842F0-9A65-4C51-A953-770F28CD7D2EQ35994634-36D290BB-3E06-4894-93AD-E22AD8F4C781Q36090600-26F668DA-7FAB-48CC-9DAB-9489D1B9DCA9Q36161264-49B4DC1B-C31B-486D-A653-81C9F0AA1600Q36219512-1515DF0C-8CDE-4CA9-906D-3C7BB2883D84Q36440902-52098B78-25BE-484A-8336-E2C6FD86E558Q36476324-0A18108B-F423-4BF6-B712-A1D6DB997C8BQ36626817-11890BDA-9038-485B-8737-431C0DB0F2D7Q36697722-EFB93D93-D55F-4FC1-BCF3-84C4F34DDB53Q36782683-0F6CCD18-B0FC-48C4-B2CD-8B36F3606B8EQ36794210-4F017B4C-F6B3-4984-B2F4-DA3327909A3CQ36873646-F949E553-00E1-46F2-B55F-F4B6A7B9768AQ37036751-C03134DE-6379-46AC-AABE-C8662B313A1AQ37076391-370E49B2-DAE0-4195-920E-0228C39B78FAQ37207294-75812C4C-9B53-4ABC-A5F1-6C4AFE1E9F37Q37207351-C5B069E0-13D5-493E-B652-DD8D212910CBQ37463969-3D2CFC08-B0AB-44FD-A685-B45FE533A0F8
P2860
Cardiac troponins in renal insufficiency: review and clinical implications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiac troponins in renal insufficiency: review and clinical implications.
@ast
Cardiac troponins in renal insufficiency: review and clinical implications.
@en
type
label
Cardiac troponins in renal insufficiency: review and clinical implications.
@ast
Cardiac troponins in renal insufficiency: review and clinical implications.
@en
prefLabel
Cardiac troponins in renal insufficiency: review and clinical implications.
@ast
Cardiac troponins in renal insufficiency: review and clinical implications.
@en
P2093
P1476
Cardiac troponins in renal insufficiency: review and clinical implications.
@en
P2093
Benjamin J Freda
Frederick Van Lente
Gary S Francis
W Franklin Peacock
W H Wilson Tang
P304
P356
10.1016/S0735-1097(02)02608-6
P407
P577
2002-12-01T00:00:00Z